Biotricity, Inc. (BTCY)
OTCMKTS · Delayed Price · Currency is USD
0.0953
-0.0297 (-23.76%)
Jul 31, 2026, 11:42 AM EST

Biotricity Financials Overview

Millions USD. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
161613.7912.069.647.65
Revenue Growth
16.01%16.01%14.32%25.15%26.00%126.02%
Gross Profit
12.9512.9510.568.365.444.57
Operating Income
1.691.69-2.45-8.83-15.41-16.74
Net Income
-3.13-3.13-11.94-14.93-19.53-30.22
Earnings Per Share
-0.11-0.11-0.55-1.66-2.26-3.99
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
1.581.581.431.121.1612.37
Total Debt
27.0627.0626.0923.8819.5515.35
Net Cash (Debt)
-25.48-25.48-24.67-22.76-18.39-2.98
Net Cash Growth
------
Net Cash Per Share
-0.93-0.93-1.15-2.53-2.12-0.39

Cash Flow & CapEx

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-0.72-0.72-2.38-6.69-13.55-15.16
Capital Expenditures
------0.03
Free Cash Flow
-0.72-0.72-2.38-6.69-13.55-15.19
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
80.94%80.94%76.61%69.27%56.46%59.74%
Operating Margin
10.57%10.57%-17.76%-73.18%-159.87%-218.77%
Pretax Margin
-15.03%-15.03%-61.07%-116.84%-193.57%-380.78%
Profit Margin
-19.55%-19.55%-86.60%-123.75%-202.65%-395.01%
FCF Margin
-4.49%-4.49%-17.26%-55.49%-140.55%-198.60%

Valuation

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJul '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PS Ratio
0.140.420.631.162.8917.39